Company Profile
Guangzhou Baiyunshan Pharmaceutical provides the pharmaceutical and healthcare industry in the People's Republic of China and globally. Its operations are structured into Modern Chinese Medicine Business, Chemical Pharmaceutical Technology Business, Natural Beverage Business, Pharmaceutical Commercial Business, and segments. It is involved in the research, development, manufacturing, and sale of chemical drugs, chemical raw materials, and chemical raw material intermediates.
Its portfolio also includes research, development, production, and sale of health products, and wholesale, retail, and import export of Western medicines, traditional Chinese medicines, and medical devices Bio-innovation, consumer health, and medical services.
Its portfolio also includes Xiaochaihu granules, Qingkailing and Baoji, Xia Sangju product series, Angong Niuhuang, Zishen Yutai, Xiaoke, Huatuo Zaizao, Zhuangyao Jianshen, and Shujin Jianyao pills, compound Danshen and Naoxinqing tablet series, Banlangen, Compound Banlangen, and Dashen Kouyanqing granules series, and honey-processed Chuanbei and Shedan Chuanbei loquat syrup.
Additionally, it provides antibacterial and anti-inflammatory drugs, andrological drugs, and analgesics and antipyretics. Its portfolio also includes Wanglaoji herbal tea, Ciningji series, Lixiaoji series, and Yerou coconut milk, and advertising services, as well as the medical research industry. Its portfolio also includes technology services industry, leasing and business services, and scientific research and technical services industry.
Its business is organized into hospitals, community healthcare facilities, and retail outlets through distributors and agents. Formerly known as Guangzhou Pharmaceutical Company Limited, the company rebranded as Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China.